Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Yulia Stroylova"'
Autor:
Yulia Stroylova, Anastasiia Konstantinova, Victor Stroylov, Ivan Katrukha, Fedor Rozov, Vladimir Muronetz
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 498 (2023)
Interactions of key amyloidogenic proteins with SARS-CoV-2 proteins may be one of the causes of expanding and delayed post-COVID-19 neurodegenerative processes. Furthermore, such abnormal effects can be caused by proteins and their fragments circulat
Externí odkaz:
https://doaj.org/article/6739700938bf46c097db1d9bb6dcc1ed
Autor:
Maria Medvedeva, Natalia Kitsilovskaya, Yulia Stroylova, Irina Sevostyanova, Ali Akbar Saboury, Vladimir Muronetz
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2255 (2022)
Earlier we showed that derivatives of hydroxycinnamic acids prevent amyloid transformation of alpha-synuclein and prion protein. The aim of this work was to determine the content of 3-hydroxycinnamic acid derivatives in coffee extracts and to evaluat
Externí odkaz:
https://doaj.org/article/207df49ff09a432d9fab0f5c3add4772
Autor:
Vladimir I. Muronetz, Kseniya Barinova, Sofia Kudryavtseva, Maria Medvedeva, Aleksandra Melnikova, Irina Sevostyanova, Pavel Semenyuk, Yulia Stroylova, Matej Sova
Publikováno v:
Molecules, Vol 25, Iss 20, p 4647 (2020)
This review presents the main properties of hydroxycinnamic acid (HCA) derivatives and their potential application as agents for the prevention and treatment of neurodegenerative diseases. It is partially focused on the successful use of these compou
Externí odkaz:
https://doaj.org/article/3fcc24372d624e65bc52039c9ab3a8bf
Autor:
Anastasia Konstantinova, Victor Stroylov, Denis Pozdyshev, Matej Sova, Saboury Ali Akbar, Vladimir Muronetz, Yulia Stroylova
Publikováno v:
Mendeleev Communications. 33:334-336
Autor:
Ivan, Zanyatkin, Yulia, Stroylova, Sofia, Tishina, Victor, Stroylov, Aleksandra, Melnikova, Thomas, Haertle, Vladimir, Muronetz
Publikováno v:
Phytotherapy Research
Phytotherapy Research, Wiley, 2017, 31 (7), pp.1046-1055. ⟨10.1002/ptr.5824⟩
Phytotherapy Research, Wiley, 2017, 31 (7), pp.1046-1055. ⟨10.1002/ptr.5824⟩
Neurodegenerative diseases are associated with accumulation of amyloid-type protein misfolding products. Prion protein (PrP) is known for its ability to aggregate into soluble oligomers that in turn associate into amyloid fibrils. Preventing the form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::79fac336522ddd6020b4acddc39f3798
https://hal.archives-ouvertes.fr/hal-01607423
https://hal.archives-ouvertes.fr/hal-01607423